期刊文献+

生长抑素14肽对胰十二指肠切除术后胰瘘的预防作用 被引量:11

Preventive effect of somatostatin on pancreatic fistula in pancreticoduedenectomy
原文传递
导出
摘要 目的观察生长抑素14肽在胰十二指肠切除术后抑制胰液的分泌、预防和治疗胰瘘的作用。方法回顾性分析本院2002年1月至2010年11月收治的进行胰十二指肠切除术患者共42例,全部病例术后常规肠外营养及抗生素治疗,其中24例术后预防性应用生长抑素14肽作为试验组,与18例术后未用者进行对照,比较2组术后并发症和胰瘘的发生率、胰液分泌量及胰周淀粉酶含量。结果治疗组的术后并发症和胰瘘的发生率、胰液分泌量以及胰周淀粉酶含量明显低于对照组,差异有统计学意义。结论用生长抑素14肽能降低胰十二指肠切除术后并发症的发生率。 Objective To explore the effect of somatostatin on inhibiting pancreatic secretion as well as preventing and curing pancreatic fistula in patients underwent pancreatodudenectomy.Methods The data of 42 pancreticoduedenectomy patients were collected retrospectively and analyzed.Somatostatin was prophylactic used in 24 cases as treatment group.The other 18 patients did not receive any somatostatin after operations as control.Conventional parenteral nutrition and antibiotics were used in all patients.The incidence of pancreatic fistula,the quantity of pancreatic juice and peripancreatic amylase were analyzed.Results The postoperative complications and the incidence of pancreatic fistula,the quantity of pancreatic juice and peripancreatic amylase in treatment group were significant lower than those of the control group(P0.05).Conclusion The prophylactic use of somatostatin are necessary and can reduce the incidence of postoperative complications of pancreatodudenectomy.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2012年第2期93-95,共3页 The Chinese Journal of Clinical Pharmacology
关键词 生长抑素14肽 胰十二指肠切除术 胰瘘 somatostatin pancreatodudenectomy pancreatic fistula
  • 相关文献

参考文献6

  • 1Suec B, Msika S, Fingerhut A, et al. Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intraabdominal com- plications after pancreatic resection: prospective randomized trial [J]. Ann Surg,2003 ;237 : 57 -65.
  • 2Jover JM, Carabias A, Fuerte S, et al. Results of defunctionalized jejuna loop after pancreatieoduodeneetomy [ J]. Cir Esp, 2006 ; 80 : 373 - 377.
  • 3Gouillat C, Chipponi J, Baulieux C, et al. Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenecto- my [J]. Br J Surg, 2001 ;88 : 1456 - 1462.
  • 4Li LJ, Irving M. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of entericuta- neous pancreatic fistulas: asystematic review of randomized cont rolled trials[ J]. Br J Surg, 2001 ;88 : 190 - 199 .
  • 5Koti RS, Gurusamy KS, Fusai G, et al. Meta- analysis of random- ized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery : a Cochrane review [ J ]. HPB, 2010 ; 12 : 155 - 165.
  • 6曾其强,周蒙滔,韩少良,余正平,金嵘,郑明华,张启瑜.生长抑素预防胰十二指肠切除术后胰瘘及其他并发症的meta分析[J].中华普通外科杂志,2007,22(9):694-697. 被引量:10

二级参考文献12

  • 1刘威,苗雄鹰,李永国,钟德玝,黄生福,王群伟.静脉输注奥曲肽预防胰十二指肠切除术后胰瘘[J].中国普通外科杂志,2004,13(12):927-929. 被引量:15
  • 2Rosenberg L, MacNeil P, Tureotte L. Economic evaluation of the use of octreotide for prevention of complications following pancreatic resection. J Gastrointest Surg, 1999,3:225-232.
  • 3Hesse UJ, DeDecker C, Houtmeyers P, et al. Prospectively randomized trial using perioperative low-dose octreotide to prevent organ-related and general complications after pancreatic surgery and pancreatico-jejunostomy. World J Surg, 2005,29 : 1325- 1328.
  • 4Shan YS, Sy ED, Lin PW. Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors : prospective, randomized, controlled trial. World J Surg, 2003,27:709-714.
  • 5Gouillat C, Chipponi J, Baulieux J, et al. Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy. Br J Surg, 2001,88:1456-1462.
  • 6Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized randomized placebo-controlled trial. Ann Surg, 2000,232:419429.
  • 7Briceno Delgado FJ, Lopez Cillero P, Rufian Pena S, et al. Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodenopancreatectomy. Rev Esp Enferm Dig, 1998,90:687-694.
  • 8Lowy AM, Lee JE, Pisters PW, et al. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg, 1997,226:632-641.
  • 9Beguiristain A, Espi A, Balen E, et al. Somatostatin prophylaxis following cephalic duodenopancreatectomy. Rev Esp Enferm Dig, 1995,87:221-224.
  • 10Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg, 1997,226:248-257.

共引文献9

同被引文献149

引证文献11

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部